To further confirm the mechanism of MNO-863 in the treatment of obesity and related complications, we evaluated the effect of MNO-863 on GLP-1 expression in NCI-H716 cells in vitro (Figure 4K). Here, GCG is linked to obesity due to melanocortin 4 receptor deficiency.